Gut extracellular vesicles promote alcohol-induced liver injury via TLR4-regulated miRNAs
Gut extracellular vesicles promote alcohol-induced liver injury via TLR4-regulated miRNAs
批准号:
9753076
负责人:
Zhong-Bin Deng
金额:
$18.29万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-08-01 至 2022-07-31
关键词:
AddressAffectAlcoholic Liver DiseasesAlcoholsAntigensAttenuatedAutomobile DrivingCell physiologyCellsChronicColitisColon CarcinomaDataDevelopmentDietDistantEpithelialEpithelial CellsEventFoundationsFutureGoalsHepaticHepatocyteHypoxiaImmuneImmune signalingImmunotherapyImpairmentIn VitroInflammationInflammatoryInflammatory disease of the intestineInjuryInterventionIntestinal permeabilityIntestinesInvestigationKupffer CellsLeadLinkLiverLiver diseasesMacrophage ActivationMediatingMicroRNAsMolecularMyeloid CellsOutcomePathogenicityPatientsPlayPreventiveProductionProteinsPublishingRegulationRoleSeveritiesSignal TransductionTLR4 geneTestingTherapeuticTumor AngiogenesisUlcerative ColitisWorkantimicrobialbasechronic alcohol ingestionexosomeextracellularextracellular vesiclesgut microbiotagut-liver axisimmunoregulationimprovedin vivoinhibitor/antagonistinterestliver developmentliver inflammationliver injurymacrophagemicrobialmicroorganism antigenmigrationmouse modelnanoparticlenanovesiclenovelnutritionoverexpressionpreventrecruitresponsetherapeutic targettranslational studyvesicular release
中文摘要
这个项目的首要主题是探索导致酒精性免疫调节的机制。
肝病(ALD)。我们将重点关注肠道和肝脏巨噬细胞的细胞外囊泡(EV)。具体地说,
我们将研究微生物抗原如何通过TLR 4信号刺激肠道EV的产生,
这些事件在通过肠-肝轴发展ALD中的后果。新的体外和体内方法
将用于解决行动机制问题,目的是确定新的干预目标。我们
提出肠源性EV调节肝脏巨噬细胞的积累和极化,
酒精诱导的慢性炎症通过TLR 4信号传导。我们特别提出,TLR 4激活
细胞外miRNA的产生是巨噬细胞活化的关键。基于我们发表的研究成果
和其他初步数据,该提案将测试微生物抗原调节生产的假设
通过TLR 4信号传导,启动巨噬细胞之间的串扰,
肝细胞ALD。此外,我们将确定饮食相关的纳米颗粒是否携带炎症
miRNAs抑制剂在ALD中具有潜在的治疗意义。这些假设将在下面进行检验
具体目的:目的1:确定TLR 4调节的肠道EV对酒精诱导的肝脏炎症的作用
和伤害。目的2:确定通过TLR 4调节IEC miRNAs的改变是否影响了
酒精诱导的肝脏炎症和损伤。在圆满完成上述工作后,
具体目的,我们的新研究将(i)验证TLR 4激活的EV与肝细胞活化直接相关,
(ii)确定了TLR 4-细胞外miRNA轴在ALD小鼠模型中的预防潜力,
ALD和(iii)为将来研究ALD中肠道EV和细胞外miRNA的机制提供了基础
疗法
英文摘要
The overarching theme of this project is to explore the mechanisms that lead to immune regulation of alcoholic
liver disease (ALD). We will focus on extracellular vesicles (EVs) of gut and hepatic macrophages. Specifically,
we will examine how microbial antigen stimulates the production of gut EVs through TLR4 signaling and the
consequences of these events in the development of ALD via gut-liver axis. Novel in vitro and in vivo approaches
will be used to address mechanisms of action with the goal of identifying new targets for intervention. We
propose that gut-derived EVs regulate the accumulation and polarization of hepatic macrophages during
alcohol-induced chronic inflammation via TLR4 signaling. We specifically propose that TLR4-activated
extracelluar miRNAs production is the key to the activation of macrophages. Based on our published work
and other preliminary data, this proposal will test the hypothesis that microbial antigen regulates the production
of gut extracellular miRNAs through TLR4 signaling, which initiates a crosstalk among macrophages and
hepatocytes in ALD. Moreover, we will determine whether diet-associated nanoparticles carrying inflammatory
miRNAs inhibitor have potential therapeutic implications in ALD. These hypotheses will be tested in the following
Specific Aims: Aim 1: Determine the role of TLR4-regulated gut EVs on alcohol-induced liver inflammation
and injury. Aim 2: Determine whether alteration of IEC miRNAs via TLR4 modulation affects the severity
of alcohol-induced liver inflammation and injury in ALD. Following the successful completion of the above
Specific Aims, our novel studies will (i) validate TLR4 activated EVs is directly relevant to the activation of hepatic
macrophages in ALD, (ii) define the preventive potential of TLR4-extracellular miRNAs axis in a mouse model of
ALD and (iii) provide a foundation for future mechanistic investigation of gut EVs and extracellular miRNA in ALD
therapy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The role of neutral ceramidase in intestinal fucosylation and liver steatosis and inflammation
-
批准号:10632084
-
项目类别:
-
资助金额:$40.59万
-
财政年份:2022
-
负责人:Zhong-Bin Deng
-
依托单位:
The role of neutral ceramidase in intestinal fucosylation and liver steatosis and inflammation
-
批准号:10517197
-
项目类别:
-
资助金额:$41.32万
-
财政年份:2022
-
负责人:Zhong-Bin Deng
-
依托单位:
Defining the role of S1p and myeloid cells during enterotoxigenic B. fragilis infection
-
批准号:10493352
-
项目类别:
-
资助金额:$19.56万
-
财政年份:2021
-
负责人:Zhong-Bin Deng
-
依托单位:
Defining the role of S1p and myeloid cells during enterotoxigenic B. fragilis infection
-
批准号:10369893
-
项目类别:
-
资助金额:$23.41万
-
财政年份:2021
-
负责人:Zhong-Bin Deng
-
依托单位:
Gut extracellular vesicles promote alcohol-induced liver injury via TLR4-regulated miRNAs
-
批准号:9804746
-
项目类别:
-
资助金额:$15.4万
-
财政年份:2018
-
负责人:Zhong-Bin Deng
-
依托单位:
CSN8 regulation of S1P-enriched extracellular vesicles to modulate NAFLD by gut-liver axis
-
批准号:9913998
-
项目类别:
-
资助金额:$40.36万
-
财政年份:2018
-
负责人:Zhong-Bin Deng
-
依托单位:
CSN8 regulation of S1P-enriched extracellular vesicles to modulate NAFLD by gut-liver axis
-
批准号:10392896
-
项目类别:
-
资助金额:$39.06万
-
财政年份:2018
-
负责人:Zhong-Bin Deng
-
依托单位:
Intestinal epithelial cells-derived exosomal miRNAs regulate liver inflammation in obesity
-
批准号:9385034
-
项目类别:
-
资助金额:$23.1万
-
财政年份:2017
-
负责人:Zhong-Bin Deng
-
依托单位:
High fat diet induced hepatocyte exosomes-promoted hepatic inflammation and tumorigenesis
-
批准号:8813882
-
项目类别:
-
资助金额:$18.47万
-
财政年份:2016
-
负责人:Zhong-Bin Deng
-
依托单位:
High fat diet induced hepatocyte exosomes-promoted hepatic inflammation and tumorigenesis
-
批准号:9293342
-
项目类别:
-
资助金额:$18.92万
-
财政年份:--
-
负责人:Zhong-Bin Deng
-
依托单位:
海外基金